Kenzi Riboulet-Zemouli
Photo credit: © WIPO, 2024.
Research interests:
- History of pharmacy — in Catalonia & Occitania — in the Mediterranean cultural basin
- History of ‘drugs’ — History of medicine — History of ‘cannabis’ (hemp)
- History of knowledges — History of science and technology
- Traditional Knowledge — Genetic Resources — Intellectual Property — Biopiracy
- International law (plants; medicines; drug control; intellectual property)
- Terminology — Time — Intertemporality in international law
Revue Politiques des Drogues, 8 (2025) 47–65
Coauteur: Farid Ghehiouèche.
Not peer-reviewed: Blog Médiapart (2025)
Coauteur: Farid Ghehiouèche.
Journal of Pharmaceutical Policy and Practice, 18, 1 (2025) 2470840
DOI: 10.1080/20523211.2025.2470840
Not peer-reviewed: Preprint Authorea (2025)
Co-author: Myrtle Clarke
DOI: 10.22541/au.173862410.09452161/v2
Phytochemistry Reviews, 24 (2025) 3307–3314
Co-authors: Petr Tarkowski, Pavel Kopecký, Ivo Frébort.
DOI: 10.1007/s11101-024-10052-y
Pharmaceuticals, 17, 12 (2024) 1585
Co-author: Josep Allué Creus.
DOI: 10.3390/ph17121585
![[PDF] Amigos de la Hoja de Coca: history of a pioneering coca leaf fair-trade](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2024/07/AHC-MANUSCRIPT-FIGURE2.jpg?fit=300%2C300&ssl=1)
Drugs, Habits and Social Policy, 25, 2 (2024) 155–172.
Co-author: Farid Ghehiouèche
DOI: 10.1108/DHS-10-2023-0040
Not peer-reviewed: Observer Written Contribution to the Proceedings of the WIPO Diplomatic Conference on Intellectual Property, Genetic Resources and Traditional Knowledge (2024)
Not peer-reviewed: Contribution to the Horizontal Working Party on Drugs, Council of the European Union (2022; released publicly in 2023)
Coauteur: Benjamin-Alexandre Jeanroy.
Not peer-reviewed: Contribution to the writing of chapters 2–6 of the United Nations Conference on Trade & Development’s Commodities at a Glance, No. 16, UNCTAD/DITC/COM/2022/1 (2022)
Author: Marco Fugazza.
![[PDF] Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/08/psychotropes-28-1-couverture.png?fit=300%2C192&ssl=1)
Psychotropes, 28, 1 (2022) 71–104.
DOI: 10.3917/psyt.281.0071
Not peer-reviewed: Preprint Authorea (2024)
Co-authors: Farid Ghehiouèche, Michael A. Krawitz.
DOI: 10.22541/au.173862410.09452161/v2 10.22541/au.165237542.24089054/v1
Paris and Washington, DC: FAAAT editions (2022)
ISBN: 979-10-97087-23-4 (PDF); 979-10-97087-24-1 (paperback)
![[PDF] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/03/DHS-paper-cover-KRZ-MK-2022.png?fit=300%2C221&ssl=1)
Drugs, Habits and Social Policy, 23, 1 (2022) 5–21
Co-author: Michael A. Krawitz
DOI: 10.1108/DHS-11-2021-0060
![[Journal] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/03/Captura-de-Pantalla-2022-03-24-a-les-21.29.31.png?fit=300%2C203&ssl=1)
Drugs, Habits and Social Policy, 23, 1 (2022) 5–21
Co-author: Michael A. Krawitz
DOI: 10.1108/DHS-11-2021-0060
Not peer-reviewed: Blog (2021)
Not peer-reviewed: Extended findings report (2021)
Co-authors: Farid Ghehiouèche, Michael A. Krawitz.
Not peer-reviewed: Résumé de mes contributions lors de mes auditions par la Mission d’Information de l’Assemblée Nationale sur la législation relative au cannabis (2021)
Not peer-reviewed: Contribution to the works of the International Narcotics Control Board (2021)
Co-author: Michael A. Krawitz.
Fac-similé: Blog, Médiapart (2021)
Drug Science, Policy and Law, 6 (2020) 1–37.
DOI: 10.1177/2050324520945797
Not peer-reviewed: Contribution to the works of the European Commission (2020)
ISBN: 979-10-97087-77-7